Professor Wilbert S. Aronow

Professor of Medicine at New York Medical College Director of Cardiology Research at Westchester Medical Center

Biography

Wilbert S. Aronow MD is Professor of Medicine and Director of Cardiology Research at Westchester Medical Center and New York Medical College Valhalla, NY, USA. Dr. Aronow received his MD from Harvard Medical School. He has edited 21 books and is author or co-author of 1,718 papers,  212 book chapters in 116 books, 960 commentaries, 50 Letters to the Editor, and 1204 abstracts and is presenter or co-presenter of 1,582 talks at meetings. Dr. Aronow is a Fellow of the ACC, the AHA, the ACP, the ACCP, the ASPC, the AGS (Founding Fellow of Western Section), and the GSA. He has been a member of 185 editorial boards of medical journals, editor-in-chief of 5 journals, co-editor of 3 journals, deputy editor of 1 journal, executive editor of 2 journals, associate editor for 9 journals, and  guest editor for 7 other medical journals, and has reviewed manuscripts for 444  journals. He has received each year from 2001-2017 an outstanding teacher and researcher award from the medical residents and  from 2001-2022 from the cardiology fellows at Westchester Medical Center/New York Medical College. He has received awards from the Society of Geriatric Cardiology, the Gerontological Society of America, New York Medical College including the 2014 Chancellor’s Research Award and the 2021 excellence in Teaching Dean’s Faculty Award, the F1000 Faculty Member of the Year Award for the Faculty of Cardiovascular Disorders in 2011, and 2013-2021, the Walter Bleifeld Memorial Award for distinguished contributions to clinical research from the International Academy of Cardiology in July, 2010, a Distinguished Fellowship Award from the International Academy of Cardiology in July, 2012, and the Expertscape World Expert in Hypertension  Award in May, 2019.  He has been a member of 4 national guidelines committees including being a coauthor of the 2010 AMDA guidelines for heart failure , co-chair and first author of the 2011 ACC/AHA expert consensus document on hypertension in the elderly, a coauthor of the 2015 AHA/ACC/ASH scientific statement on treatment of hypertension in patients with coronary artery disease, and a coauthor of the 2017 ACC/AHA  guidelines for the management of patients with hypertension. He was a coauthor of a 2015 position paper from the International Lipid Expert Forum. He was a consultant to the American College of Physicians Information and Educational Resource (PIER) on the module of aortic stenosis, a consultant to the American Board of Internal Medicine on hypertension, a member of the Board of Directors of the ASPC, a member of the ACCP Cardiovascular Medicine and Surgery Network Steering Committee, and is a member of the Scientific Executive Committee of the International Academy of Cardiology. He has been a committee member of other professional societies and a consultant to many government agencies. He has mentored 304 cardiology fellows and 669 other trainees plus numerous junior faculty for publications listed on PubMed during his professional career.

 

Expert content

LBPMC Publications

RSS Aronow WS
  • Improving Access and Outcomes in Cardiovascular Care for Racial and Ethnic Minorities 2025-12-03
    Cardiovascular disease remains the leading cause of morbidity and mortality in the United States, with racial and ethnic minority populations disproportionately affected. Persistent inequities in access to preventive, diagnostic, and therapeutic care reflect the influence of structural racism, adverse social determinants of health, and systemic barriers across the continuum of care. This literature review synthesizes […]
    Hadrian Hoang-Vu Tran
  • Corticosteroid Therapy in Cardiac Arrest: Evidence, Guidelines, and Future Directions 2025-12-01
    Cardiac arrest causes circulatory collapse, stress-related adrenal insufficiency, and a strong inflammatory response, creating a plausible rationale for corticosteroid therapy. Glucocorticoids can restore adrenergic responsiveness, raise vascular tone and blood pressure, correct inadequate cortisol activity during critical stress, and attenuate ischemia-reperfusion inflammation. Across randomized trials, the most consistent finding is a higher rate of return […]
    Robert A Abrahams
  • Pulsed-Field Ablation in Atrial Fibrillation: A Paradigm Shift in Electrophysiology 2025-12-01
    Atrial fibrillation (AF) is the most common sustained arrhythmia worldwide and remains a leading cause of stroke, heart failure, and mortality. Catheter-based ablation, primarily pulmonary vein isolation, has become a cornerstone of rhythm control, but conventional thermal approaches carry risks of collateral injury and variable long-term efficacy. Pulsed-field ablation (PFA), a nonthermal modality that employs […]
    Hadrian Hoang-Vu Tran
  • Innovations in Interventional Cardiology: A Critical Review of Strategies for Complex and High-Risk Percutaneous Coronary Intervention 2025-11-27
    The field of interventional cardiology has rapidly progressed, given recent advances in the management of complex, high-risk indicated percutaneous coronary intervention. These procedures are becoming increasingly necessary due to the aging population and increasing comorbidity burden. Expanded procedural capabilities have been made possible through innovations in mechanical circulatory support (MCS) devices, drug-coated balloons, and intravascular […]
    Ellen N Huhulea
  • Milrinone in Advanced Heart Failure: Current Evidence, Clinical Applications, and Future Directions 2025-11-26
    Positive inotropic agents have an important role in the management of acute decompensated heart failure patients with reduced cardiac output and poor end-organ perfusion. However, despite their acute hemodynamic benefits, the role of inotropes in the management of chronic advanced heart failure remains limited to palliative therapy or as a bridging strategy to mechanical support […]
    Cristian Castillo-Rodriguez
  • Coronary Collaterals: A Comprehensive Review 2025-11-17
    Coronary collateral circulation consists of pre-existing arterial connections that can be recruited and enlarged when a coronary stenosis develops. This review traces their developmental and anatomic basis and summarizes how metabolic and inflammatory milieu modulate growth. We appraise assessment methods, showing the limits of visual angiographic grading and emphasizing a function-first approach that includes the […]
    Negarsadat Neshat
  • The Autonomic Nexus: Neuromodulation as a New Frontier in Arrhythmia Therapy 2025-11-17
    Cardiac autonomic modulation has emerged as a novel therapeutic frontier for atrial and ventricular arrhythmias, addressing the limitations of conventional anti-arrhythmic drugs, ablation, and device therapies. This review summarizes recent progress in neuromodulation, focusing on mechanistic foundations, clinical applications, safety considerations, and future directions. Neuromodulatory techniques such as ganglionated plexus ablation, vagus nerve stimulation, renal […]
    Hadrian Hoang-Vu Tran
  • High-Density Lipoprotein Dysfunction and Atherosclerotic Cardiovascular Disease: From Quantity to Quality 2025-11-14
    High-density lipoprotein cholesterol (HDL-C) has long been inversely associated with atherosclerotic cardiovascular disease risk, but pharmacologic efforts to raise HDL-C have consistently failed to reduce cardiovascular events. This has shifted focus from HDL quantity to quality, emphasizing functional properties such as cholesterol efflux, antioxidative capacity, and anti-inflammatory activity. Dysfunctional HDL, often modified by oxidative and […]
    Amogh Jyothi Arun
  • Managing Hyperkalemia in Heart Failure Patients: A Systematic Review 2025-11-14
    Hyperkalemia is a common and potentially life-threatening electrolyte abnormality in patients with heart failure, particularly among those with diabetes or chronic kidney disease. It often results from the use of renin-angiotensin-aldosterone system inhibitors, which, while improving survival, increase serum potassium levels. Elevated potassium produces cardiotoxic effects, often recognized by characteristic electrocardiographic changes. Acute management focuses […]
    Mahesh Kumar
  • From Pathways to Patients: Contemporary Approaches to Pulmonary Hypertension 2025-11-12
    Pulmonary hypertension (PH) is a heterogeneous and progressive condition defined by elevated mean pulmonary arterial pressure, classified into 5 groups based on underlying etiology and pathophysiology. Affecting millions worldwide, PH carries a poor prognosis, particularly in pulmonary arterial hypertension (group 1). From a cardiology perspective, advancing PH management is essential given the central role of […]
    Cristian Castillo-Rodriguez
  • Aspirin for Primary Prevention of Cardiovascular Disease: A Contemporary Review 2025-11-08
    Aspirin has been fundamental in secondary prevention of cardiovascular disease (CVD) due to its antithrombotic effect. Its use in primary prevention, that is, preventing first-time cardiovascular events in persons without known CVD, has been controversial. Early trials, which were done in the late 20th century, showed moderate myocardial infarction reductions with aspirin, but they also […]
    Darshilkumar Maheta
  • Statins and the Cardio-Hepatic Axis: Balancing Cardiovascular Protection with Liver Disease Safety 2025-11-08
    Statins, traditionally viewed with caution in liver disease due to concerns about hepatotoxicity, are now increasingly recognized as both safe and potentially beneficial in this population. Recent evidence demonstrates that clinically significant liver injury from statins is exceedingly rare, while mild aminotransferase elevations are usually transient and adaptive. Large trials and real-world studies confirm that […]
    Omar Alkasabrah
  • Cardiovascular Manifestations of Thyroid Disorders: Mechanisms, Diagnosis, and Management 2025-11-06
    Thyroid dysfunction is a known cause of cardiovascular disturbance, both as a precipitant of cardiovascular pathology and a mimic of underlying heart disease. These can mostly be categorized under 3 headings: arrhythmias, heart failure (HF), and vascular dysfunction. New research has unearthed the mechanistic links of the thyro-cardiac axis to the pathophysiology of cardiac electrophysiology, […]
    Lana Tannous
  • Inflammation-Driven Arrhythmias: Bridging Immunology and Electrophysiology 2025-11-06
    Cardiac arrhythmias, including atrial fibrillation, ventricular tachycardia, and sudden cardiac death, remain a leading cause of morbidity and mortality worldwide. While traditional models of arrhythmogenesis have focused on structural remodeling and ion channel dysfunction, emerging evidence highlights the pivotal role of immune-inflammatory processes in shaping arrhythmic substrates. This review synthesizes current knowledge on the immunobiology […]
    Hadrian Hoang-Vu Tran
  • Cardiac Manifestations of Nutritional Deficiencies 2025-11-06
    Nutritional deficiencies remain an important yet underrecognized cause of cardiovascular morbidity worldwide. Our review examines how deficiencies in key micronutrients and macronutrients lead to distinct cardiac manifestations, ranging from structural alterations to functional impairments. We begin with water-soluble vitamins, highlighting classic manifestations like thiamin deficiency and wet beriberi, later pyridoxine, folate, cobalamin, and ascorbic acid. […]
    Lillian Huang
  • Syphilitic Cardiac and Vascular Disease: A Comprehensive Review 2025-11-06
    Syphilis incidence has been rising worldwide over the last few decades, raising concern for a resurgence of tertiary complications. Syphilitic cardiovascular disease is a rare but serious manifestation of tertiary syphilis, formerly a major cause of aortitis and thoracic aortic aneurysms before the antibiotic era. This review provides an updated overview of syphilitic cardiac and […]
    Darshilkumar Maheta
  • Giant Cell Myocarditis: An Updated Review of Pathogenesis, Clinical Presentation, and Modern Management Approaches 2025-11-06
    Giant cell myocarditis is a rare cardiac disorder that can lead to rapid deterioration and poor outcomes. It presents with a wide array of symptoms, including heart failure, ventricular arrhythmias, or atrioventricular block. Its features overlap with other inflammatory cardiac conditions, particularly cardiac sarcoidosis, which can lead to diagnostic challenges. Diagnostic modalities, including cardiac magnetic […]
    Sara Elattar
  • Role of FGF21 in Heart Failure: Molecular Insights and Therapeutic Implications 2025-11-06
    Fibroblast growth factor 21 (FGF21) has emerged as a key metabolic hormone with cardioprotective roles in heart failure (HF). It is produced by the liver, adipose tissue, and cardiomyocytes and acts through fibroblast growth factor receptor 1/β-Klotho to regulate glucose uptake, fatty acid oxidation, mitochondrial function, and adaptive stress responses. Experimental models show that FGF21 […]
    Siddharth Pravin Agrawal
  • Annular Aortic Valve Enlargement Versus Transcatheter Aortic Valve Replacement in Women With Small Aortic Annulus: Contemporary Evidence, Challenges, and Future Directions 2025-11-02
    Women with severe aortic stenosis frequently have small aortic annuli, predisposing them to prosthesis-patient mismatch after valve replacement. Surgical annular aortic valve enlargement (AAVE) during aortic valve replacement and transcatheter aortic valve replacement (TAVR) are the principal strategies to optimize hemodynamics in this setting. This review compared contemporary evidence on AAVE and TAVR in women […]
    Rimsha Ahmad
  • Update From the 2015 American Heart Association/American College of Cardiology Hypertension Guidelines 2025-10-30
    The 2017 American College of Cardiology/American Heart Association hypertension guidelines were published in 2018. This review is an update of these guidelines reported in 2025.
    Wilbert S Aronow